GLP-1 Medications and Medicare: What Seniors Need to Know About Ozempic, Wegovy, Mounjaro, and Zepbound

By William Gray — The Medicare Dude

Over the past several years, GLP-1 medications have become one of the biggest topics in healthcare. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have transformed the conversation around obesity, diabetes, heart disease, and healthy aging.

For many seniors in Florida and across the country, these medications are creating new opportunities to improve health, lose weight, reduce complications from chronic disease, and potentially extend independence later in life.

But there is one major challenge: how do these medications fit into Medicare?

As an independent Medicare broker helping beneficiaries since 1998, I receive questions every week from clients asking:

• Does Medicare cover Ozempic?
• Does Medicare pay for Wegovy?
• Will my Medicare Advantage plan cover GLP-1 drugs?
• Why is my copay so high?
• Can changing plans save me money?

The answers are not always straightforward — but understanding how GLP-1 medications interact with Medicare coverage can potentially save beneficiaries thousands of dollars annually.

GLP-1 stands for Glucagon-Like Peptide-1. These medications mimic a naturally occurring hormone in the body that helps regulate blood sugar, appetite, digestion, insulin production, and feelings of fullness. By slowing stomach emptying and reducing hunger signals, these medications often result in significant weight loss.

The most commonly discussed GLP-1 medications include:

Ozempic — Approved for Type 2 Diabetes. One of the most widely prescribed GLP-1 medications in the country.

Wegovy — Approved for obesity and weight management. Same active ingredient as Ozempic (semaglutide) but at a higher dose.

Mounjaro — Approved for Type 2 Diabetes. A dual GIP/GLP-1 receptor agonist with strong clinical results.

Zepbound — Approved for obesity and weight management. Same active ingredient as Mounjaro (tirzepatide) but indicated for weight loss.

Rybelsus — An oral GLP-1 medication for Type 2 Diabetes.

Victoza — An earlier GLP-1 option still used by some patients.

Weight gain often becomes more challenging after age 60. Many Medicare beneficiaries struggle with diabetes, high blood pressure, sleep apnea, arthritis, heart disease, and mobility issues — and excess weight can worsen all of these conditions.

Clinical studies have shown some GLP-1 medications can produce weight loss of 15% to 25% of body weight in certain patients. For a 250-pound person, that could mean 37 to 62 pounds lost — changes that can dramatically affect blood pressure, A1C levels, joint pain, energy levels, and overall quality of life.

Ozempic is generally prescribed for Type 2 Diabetes. Because it is approved for diabetes treatment, Medicare Part D plans often provide coverage.

However, coverage varies significantly by carrier. Copays vary by plan. Deductibles may apply. Formularies change annually. One Medicare Advantage plan may have significantly lower costs than another for the exact same medication.

If you are taking Ozempic and approaching Medicare eligibility — or already enrolled — a plan comparison focused specifically on your medication costs is essential.

Historically, Medicare has not covered medications used solely for weight loss. This is rooted in a longstanding statutory exclusion for weight loss drugs in Medicare Part D.

However, recent developments involving cardiovascular risk reduction have begun changing the landscape. The FDA approved Wegovy for reducing the risk of serious cardiovascular events in adults with cardiovascular disease and obesity or overweight — and this cardiovascular indication has opened new coverage discussions.

Coverage opportunities continue evolving. Beneficiaries should review their plans annually because formulary updates occur every year and the regulatory environment around GLP-1 coverage is actively shifting.

This is where plan comparisons become extremely valuable.

Not all Medicare Advantage plans treat GLP-1 medications the same. Differences between plans may include:

• Monthly cost-sharing
• Prior authorization requirements
• Preferred pharmacy networks
• Quantity limits
• Coverage restrictions based on diagnosis

A beneficiary paying hundreds of dollars per month on one plan may find substantially different costs on another plan in the same ZIP code. This is exactly why a personalized plan comparison — not just a premium comparison — matters so much for beneficiaries taking these medications.

GLP-1 medications can be expensive. Without insurance coverage, costs may exceed $800 to $1,300 per month depending on the medication and dosage.

For retirees living on fixed incomes, these expenses can create serious financial pressure. This makes Medicare plan selection more important than ever for anyone taking — or considering — a GLP-1 medication.

The good news: the Medicare Part D $2,000 out-of-pocket cap that took effect in 2025 provides meaningful protection for beneficiaries with high drug costs. Once you reach $2,000 in out-of-pocket drug spending in a calendar year, your Part D costs drop to zero for the rest of the year.

Many Americans begin using GLP-1 medications before age 65 through employer insurance, ACA Marketplace plans, or individual health insurance. Then they transition to Medicare.

This creates what I call the GLP-1 Bridge — the transition period where someone is successfully taking a GLP-1 medication before Medicare and must determine how that medication will be covered once Medicare begins.

This is one of the most overlooked Medicare planning issues today.

When someone turns 65 while taking a GLP-1 medication, several questions become critical:

Is the medication covered? Coverage depends on the plan's formulary — and formularies vary significantly between plans.

What tier is the drug on? Different tiers create different costs. A Tier 3 drug costs more than a Tier 2 drug, and a Tier 5 specialty drug costs more than either.

Is prior authorization required? Many plans require approval before covering GLP-1 medications, often requiring documentation of a qualifying diagnosis.

Are step therapy requirements involved? Some plans require trying other medications first before approving a GLP-1.

Is the medication covered only for diabetes? This is a major distinction. A plan may cover Ozempic for diabetes but not cover Wegovy for weight loss — even though both contain semaglutide.

If you are currently taking a GLP-1 medication and approaching Medicare eligibility, your plan selection should be driven in large part by how each available plan covers your specific medication.

Many beneficiaries choose a Medicare plan and never review it again. That can become costly.

Every year, formularies change, networks change, drug tiers change, and copays change. A plan that covered your GLP-1 medication at a low cost last year may have moved it to a higher tier — or removed it from the formulary entirely.

If a GLP-1 medication is important to your health, an annual Medicare review becomes essential. The Annual Enrollment Period runs from October 15 to December 7 each year. This is your opportunity to compare plans and switch if a better option is available.

Researchers continue studying GLP-1 medications for benefits beyond weight loss. Potential areas of ongoing research include cardiovascular health, kidney disease, sleep apnea, inflammation, and cognitive health.

As research expands, Medicare coverage policies may continue evolving. Beneficiaries should expect ongoing changes in this area over the next several years — which makes staying current on your plan's formulary even more important.

In areas like Daytona Beach, Palm Coast, Jacksonville, St. Augustine, Ormond Beach, and New Smyrna Beach, many retirees are actively discussing GLP-1 medications with their physicians.

As obesity, diabetes, and heart disease remain common among Medicare-age adults, these medications are likely to become an increasingly important part of retirement healthcare planning in Florida.

When evaluating Medicare coverage, most people focus on premiums. The bigger question is often: "What happens when I actually need healthcare?"

Prescription medications can have a larger financial impact than the monthly premium itself. For beneficiaries taking Ozempic, Wegovy, Mounjaro, Zepbound, or similar medications, choosing the right Medicare plan can significantly affect annual healthcare costs.

That is why every Medicare review should include your current medications, future medication needs, preferred pharmacies, physician recommendations, and budget considerations. The goal is not simply finding the cheapest plan — the goal is finding the plan that best supports your healthcare needs and financial situation.

GLP-1 medications are changing healthcare in America. For Medicare beneficiaries, these medications create both opportunities and challenges. Whether you are currently taking one of these medications or considering one in the future, understanding how Medicare coverage works is essential.

If you are approaching Medicare eligibility or already enrolled and have questions about GLP-1 coverage, a personalized Medicare review can help you understand your options and avoid costly surprises.

William Gray is an independent Medicare broker and owner of The Medicare Dude, helping Medicare beneficiaries navigate Medicare Advantage, Medicare Supplement, and Part D prescription drug coverage since 1998. He serves clients throughout Flagler County, Volusia County, and Northeast Florida.

Call (386) 871-3858 or schedule a free consultation to review your Medicare plan options.